Fanhua announced that it has recently received a resignation letter from Peh Chin Hua, tendering his resignation from the board as director and chairman of the board for personal reasons. The board has accepted his resignation, effective immediately.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FANH:
- Fanhua Announces Change to the Board of Directors
- Fanhua announces partnership with Shanghai Biotecan Pharmaceuticals
- Fanhua BluePlus Forming Strategic Partnerships with Shanghai Biotecan Pharmaceuticals
- Fanhua to Unveil H1 2024 Financial Outlook
- Fanhua to Announce 2024 First Half Unaudited Financial Results on September 18, 2024